Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

237.10
+0.54000.23%
Pre-market: 236.99-0.1100-0.05%07:57 EDT
Volume:1.85M
Turnover:433.72M
Market Cap:31.64B
PE:42.19
High:239.08
Open:224.47
Low:223.61
Close:236.56
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.15
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.36
PE(LYR):101.76

Loading ...

May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities